Awareness of Digital Reporting of Adverse Drug Events among Health Care Professionals | ||
| International Journal of Medical Arts | ||
| Article 13, Volume 5, Issue 9, September 2023, Pages 3676-3681 PDF (927.7 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ijma.2023.234030.1801 | ||
| Authors | ||
| Shweta Sharma1; Dinesh Kumar Yadav1; Ashutosh Kumar Singh* 1; Meghna Pandey1; Komal Kuldeep Singh2 | ||
| 1Department of Pharmacology, AlFalah School of Medical Sciences and Research, Faridabad, Haryana, India | ||
| 2Haryana Civil Medical Services, Haryana, India | ||
| Abstract | ||
| Background: Digital reporting of adverse events remains the most important tool to improve pharmacovigilance information related to drugs introduced in the market with good efficacy and limited safety knowledge perceived from clinical trials. Aim of the Study: The study aimed to identify the knowledge and awareness of digital reporting of adverse drug events among healthcare professionals working at a tertiary care hospital in India. Materials and Methods: A cross-sectional descriptive questionnaire-based study was conducted with Physicians, Pharmacists, Technicians and Nurses. The questionnaire comprised items regarding awareness of pharmacovigilance and digital reporting of ADRs and perception and attitudes of healthcare professionals in digital reporting of adverse drug events. Descriptive statistics were used to analyse the data. Results: Healthcare professionals received 200 questionnaires in total, and 200 participants responded, yielding a 100% response rate among which 108 were male and 92 were female. 98 doctors, 32 pharmacists, 11 technicians, and 59 nurses comprised the group of healthcare professionals. 72% of healthcare professionals were familiar with the phrase "pharmacovigilance." Nearly 73% of healthcare professionals did not know the method of digital reporting of ADR and their nearby pharmacovigilance centers. In addition, 88% agreed that ADRs need to be reported digitally because it is easy and convenient and 92% agreed that it is their professional responsibility. Conclusion: Our study shows that awareness of pharmaco-vigilance and digital ADR reporting among healthcare professionals is relatively low. | ||
| Keywords | ||
| Pharmacovigilance; Adverse drug events; Questionnaire; Physicians; Pharmacists | ||
|
Statistics Article View: 123 PDF Download: 162 |
||
